RxAll Nanoscanner

Quality assurance of medicines in your hands 

1 million people die across the world because of fake medicines. Africa bears the greatest burden of this problem as up to 70% of medicines on the continent tend to be of low quality(WHO). This leads to poor therapy outcomes, higher medical costs from repeat treatment and worsening of disease states. It also causes deaths with 100K+ African dying every year from poor quality medicines(WHO).

Our solution, the RxAll Nanoscanner enables medicine users assure the quality of their medicines. With the RxAll nanoscanner, Africans and their caregivers can test medicines for quality before use

Our solution will increase the quality of medicines by enabling users personally assure their medicine quality before use. 

The RxAll Nanoscanner is a new AI enhancement method of existing lab infrared spectroscopic methods in drug quality assurance. Our solution offers lay people a quality assurance lab in their hands. We are better than existing lab techniques because we enable non-destructive drug quality assurance in 20 seconds using a mobile phone app. This preserves the test sample, enables onsite quality assurance testing and  allows for remote monitoring of drug quality reports across multiple field test locations leading to faster interventions.

Through our AI and digital app interface we are able to provide a low cost tool to lay people to assure the quality of their medicines. Until now portable solutions for drug quality assurance cost $30K+ and could only be used by well trained professionals. Our solution offers a quality assurance tool at a ~$100 and enables users receive an easy to understand test result on their mobile phones.

Our goals include

1. To complete new supply chain quality assurance project across 10 facilities for a healthcare client in Ghana 

2. To complete narcotics database in North America and start opioid quality assurance testing in Vancouver, Canada

3. Build national database for Nigeria's FDA to enable use of our platform by its 600 inspectors and over 40 tertiary hospitals to assure quality of medicines in circulation across pharmacies in Nigeria

4. Start narcotics detection pilot with Nigeria's drug trafficking agency across 10 terminals of the Lagos International Airport 

Our goal is to make our platform available to every pharmacy and regulatory agency across Africa so that they can use it to test medicines before use. 

In addition, we want to provide the test results as data maps that help regulators and first responders position themselves to intervene in areas with many bad medicines.

This approach will enable us improve the quality of medicines sold across African countries. Test results will be collated into an app that helps patients know which pharmacies authenticate medicines so that they know where to get the best medicines.

We will sell to country FDAs, hospitals and pharmacies.

These stakeholders will assure the supply chain and we will create a data app that helps patients find pharmacies that go the extra mile to authenticate their medicines.

Ultimately by improving the ability of professionals to regulate and assure the medicines supply chain we increase the quality of the medicine supply chain and improve value-based therapeutic outcomes for patients.

Our sales approach involves us working with professionals on initial pilots before scaling into commercial projects.

We are currently working with a large teaching hospital in Nigeria and about to start a project with an NGO running medicine supplies for a network of hospitals in Ghana.

These are hospital pharmacy professionals who are concerned about the quality of medicines they receive and dispense to their patients. They find our solution relevant because it helps them assure the quality of medicines especially generic products, improve the quality they receive and assure that they are not buying poor quality products that harm their patients.

In 12 months, we expect to have deployed with 2 major national FDAs in Africa i.e. Nigeria and Ghana.We will build a national product database for them and provide our platform to their over 1000 inspectors who will use our solution for field testing at the ports and across pharmacies.

In 3 years, we will have our solution in use by more than 100 hospitals and pharmacies in Nigeria and Ghana. We will also have an app that helps thousands of patients find pharmacies that authenticate their supplies. Households will also be able to buy and use our platform directly.

Technical capacity and research background- our CTO-Wei graduated with a PhD from Yale school of chemistry where he developed the tech behind our solution. Our CEO is a pharmacist and has a solid understanding of the pharma industry.

Go to market and market development experience- our CMO-Amy worked 5 years on go to market strategy with Google. Our CEO- Ade has 8 years market development experience with the Boston Consulting Group and Roche where he made sales of $1M+ in West-Central Africa.

We sell our hardware and make recurring annual revenue of ~$10K per sold device. This recurring revenue comes from each scan done on the device.

We sell to regulators and pharmacies.

The average regulator has about 400 inspectors and there are up to 5000 pharmacies per target  country in Africa. This offers a recurring revenue market potential of ~$3B.

Our solution is scalable because as we set up each country FDA, we dont have to repeat the database development and become immediately accessible to pharmacies in target countries 

Solve provides us a platform to secure talent to help us grow our platform.

It also offers us the exposure to potential partners especially in North America as we seek to expand our application to solve the opioid contamination crisis that killed 70k people last year in the USA and Canada.

Further, the feedback we receive would help us improve our business model and explore applications and go to market approaches we may have overlooked

Securing the right partnerships- we need a network that can help us secure partnerships with country FDAs and stakeholders working in the pharma and opioid quality control fields. To scale faster Solve can connect us with the people who can help us make these connections so we secure projects faster.

Capital adequacy- we are a hardware/software play and require the right level of capital for product development, pilots and the long sales cycle. Solve can connect us with Social Impact Investors who can ensure we have the right level of capital to fund our growth.